Nucleoside transport inhibition by draflazine in unstable coronary disease

European Journal of Clinical Pharmacology

Volumn 51, Issue 1, 1996, Pages 7-13

  Andersen, K ^a   Dellborg, M ^a   Swedberg, K ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenosine; Angina pectoris; Draflazine; Ischaemia; Nucleoside transport inhibitors; Unstable angina; Vectorcardiography

Indexed keywords

DRAFLAZINE; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEART INFARCTION; HEART PROTECTION; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA, UNSTABLE; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES;

EID: 0029777547     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050153     Document Type: Article

References (30)

1. Ely SW, Berne RM (1992) Protective effects of adenosine in myocardial ischemia. Circulation 85:893-904
2. Hori M, Kitakaze M (1991) Adenosine, the heart, and coronary circulation. Hypertension 18:565-574
3. Ely SW, Mentzer RM, Lasley RD, Lee BK, Berne RM (1985) Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 90:549-556
4. Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807-813
5. Hori M, Kitakaze M, Tamai J, Koretsune Y, Iwai K, Iwakura K, Kagiya T, Kitabatake A, Inoue M, Kamada T (1988) α-2-adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery. Am J Physiol 255: H250-H260
6. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595-1606
7. Richardt G, Waas W, Kranzhöfer R, Mayer E, Schömig A (1987) Adenosine inhibits exocyte release of endogenous noradrenaline in rat heart: A protective mechanism in early myocardial ischemia. Circ Res 61:117-123
8. Belardinelli L, Isenberg G (1983) Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 53:287-297
9. Sato H, Hori M, Kitakaze M, Takashima S, Inoue M, Kitabatake A, Kamada T (1992) Endogenous adenosine blunts β-adrenoceptor-mediated inotropic respons in hypoperfused canine myocardium. Circulation 85:1594-1603
10. Agarwal KC, Zielinski BA, Maitra RS (1989) Significane of plasma adenosine in the antiplatelet activity of forskolin: Potentiation by dipyridamole and dilazep. Thromb Haemostas 61:106-110
11. Kitakaze M, Hori M, Sato H, Takashima S, Inoue M, Kitabatake A, Kamada T (1991) Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 69:1402-1408
12. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R (1986) Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 78: 760-770
13. De la Harpe J ,Nathan CF (1989) Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces. J Immunol 143:596-602
14. Belardinelli L, Linden J, Berne R (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97
15. Parkinson FE, Clanachan AS (1991) Adenosine receptors and nucleoside transport sites in cardiac cells. Br J Clin Pharmacol 104:399-405
16. Van Belle H (1993) Nueleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine?' Cardiovasc Res 27:68-76
17. Chang-Chun C, Masuda M, Szabó Z, Szerafin T, Szécsi J, Van Belle H, Flameng W (1992) Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crosselamping. J Thorac Cardiovasc Surg 104: 1602-1609
18. Flameng W, Daenen W, Borgers M, Thoné F, Xhonneux R, van de Water A, van Belle H (1981) Cardioprotective effects of lidoflazine during 1-hour normo-thermic global ischemia. Circulation 64:796-807
19. Flameng W, Xhonneux R, Van Belle H, Borgers M, van de Water A, Wouters L, Wijnants J, Thoné F, van Daele P, Janssen PAJ (1984) Cardioprotective effects of mioflazine during 1 h normothermic global ischaemia in the canine heart. Cardiovasc Res 18:528-537
20. Wood AJ, Isted K, Hynd J, Main MJ, Noble MIM, Parker J, Drake-Holland AJ (1985) Mioflazine, a potentially protective drug against ischaemic damage: A study in dogs. Eur Heart J 6:695-701
21. Van Belle H, Verheyen W, Ver Donck K, Janssen PAJ, Robertson JIS (1992) Prevention of Catecholamine-Induced Cardiac Damage and Death with a Nucleoside Transport Inhibitor. J Cardiovasc Pharmacol 20:173-178
22. Masuda M, Chang-Chun C, Mölhoff T, Van Belle H, Flameng W (1992) Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts. J Thorac Cardiovasc Surg 104:1610-1617
23. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, Sun J-Z, Sekili S, Tang X-L, Bolli R (1993) Augmentation of endogenous adenosine attenuates myocardial "stunning" independently of coronary flow or haemodynamic effects. Circulation 88: 2359-2369
24. Abd-Elfattah AS, Ding M, Dyke CM, Wechsler AS (1993) Protection of the stunned myocardium. Selective nucleoside transport blocker administered after 20 minutes of ischemia augments recovery of ventricular function. Circulation 88:II 336-343
25. Dellborg M, Gustavsson G, Riha M, Swedberg K (1992) Dynamic changes of the QRS-complex in unstable angina pectoris. Int J Cardiol 36:151-162
26. Reference deleted
27. Itoya M, Miura T, Sakamotao J, Urabe K, Iimura O (1994) Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning. J Cardiovasc Pharmacol 24:846-852
28. Verborgh C, Van Gool R, Lauwers M, Dupot A, Camu F (1994) Haemodynamic effects of Draflazine in CABC patients. (abstract) J Cardiothor Vasc Anest 8 [Suppl 3]:6 EACTA 94. European Association of Cardiothoracic Anaesthesiologists 9th annual meeting. Turku, Finland:, (abstract)
29. Verborgh C, Van Gool R, Lauwers M, Dupot A, Camu F (1994) Haemodynamic effects of Draflazine in CABC patients. (abstract) J Cardiothor Vasc Anest 8 [Suppl 3]:6 EACTA 94. European Association of Cardiothoracic Anaesthesiologists 9th annual meeting. Turku, Finland:, (abstract)
30. van der Starre PJA, Bakhuizen R, Nanninga J, de Kluiver EP, Van Gool R, de Vries A (1994) Cardioprotective effect of nucleoside-transport inhibition in patients undergoing coronary artery bypass grafting (CABG). Anesthesia Research Society. Orlando, Florida, USA:, (abstract) Anest Analg 78:S454